← Browse by Condition
Medical Condition

refractory pancreatic carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05053971 Phase 1, Phase 2
Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →